13MAY

Elliptic closes $120m crypto compliance round

4 min read

20:05UTC

Elliptic, London's blockchain analytics company, closed a $120m Series D on 12 May at a $670m valuation, with Nasdaq Ventures and Deutsche Bank co-investing alongside the British Business Bank's £13m contribution.

← Back to State capital lands on UK tech in nine days Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Elliptic's $120m round with Nasdaq Ventures and Deutsche Bank confirms institutional demand for external crypto compliance tooling over in-house builds.

Elliptic, London's blockchain analytics and crypto compliance company, closed a $120m Series D on 12 May 2026 at a $670m valuation. ¹ One Peak led; Nasdaq Ventures, Deutsche Bank, and the British Business Bank (BBB) co-invested. The BBB contributed £13m using two instruments simultaneously: the British Growth Partnership Fund I and the core BBB balance sheet, demonstrating broader use of the expanded toolkit the bank received from April 2026.

Elliptic screens over one billion crypto transactions weekly for more than 700 customers across 30 countries. Its platform serves institutional compliance teams at banks, exchanges, and asset managers navigating the Financial Conduct Authority's (FCA) 2026 liberalisation of crypto and digital assets authorisation in the UK. The FCA named its second AI Live Testing cohort on 21 April 2026 , a regulatory signal that institutional financial services players are actively building infrastructure to operate in the new regulatory environment.

The co-investor profile carries structural weight. Nasdaq Ventures investing in crypto compliance signals that a major exchange operator is building a financial interest in the governance infrastructure of the asset class it lists. Deutsche Bank's participation alongside Nasdaq Ventures suggests two distinct institutional motivations: exchange infrastructure and traditional banking compliance convergence on the same compliance tooling. Neither is building these capabilities in-house; both are taking equity positions in the external provider.

The dual BBB instrument use in a single deal is a technical signal worth tracking. The bank's direct mandate permits it to deploy capital through multiple vehicles simultaneously; doing so in a $670m-valuation deal tests whether the two instruments create any pricing tension or whether they operate as a unified position. No BBB statement has addressed the mechanics of multi-instrument co-investment pricing. For Elliptic, $120m at $670m valuation implies a substantial premium to revenue; the combined BBB position at that valuation sets a data point for how public capital prices itself in late-stage fintech infrastructure rounds.

Deep Analysis

In plain English

Elliptic is a London company that checks cryptocurrency transactions for signs of money laundering, fraud, and sanctions violations. When a bank or a crypto exchange wants to make sure their customers are not involved in illegal activity, they use tools like Elliptic's to screen transactions automatically. On 12 May 2026, Elliptic raised $120m from investors including Nasdaq (the US stock exchange), Deutsche Bank, and the British Business Bank. The company is now valued at $670m. The FCA, the UK's financial regulator, has been making it easier for companies to get authorised to handle crypto assets in 2026, which has increased demand for the compliance tools Elliptic sells.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The 2014 to 2017 build-out of SWIFT's financial messaging compliance infrastructure, where Accuity (now Dow Jones Risk and Compliance) and LexisNexis Risk Solutions both attracted strategic investment from the banks that used their services, is the closest structural precedent.

Banks and exchanges investing in their own compliance infrastructure vendors reduces the vendor's customer concentration risk while locking in the investor as a long-term customer. Nasdaq Ventures' Elliptic position follows this playbook precisely.

Counter-parallel: NICE Actimize, a financial crime analytics company, was acquired by NICE Systems in 2007 after attracting similar strategic investment from its banking customers. The acquisition pathway compresses independent equity upside: Elliptic at $670m is already within acquisition range for Deutsche Bank or Nasdaq if either decided to internalise the capability rather than maintain an equity position in an external vendor.

The BBB's dual-instrument deployment, combining the British Growth Partnership Fund I with the core balance sheet, creates a technical pricing complexity: two instruments with different mandate parameters, return expectations, and lock-up periods producing a blended position in a single deal.

No BBB statement has addressed how dual-instrument co-investment positions are priced, or how they interact if one instrument exits before the other. For Elliptic at a $670m valuation, the combined £13m BBB position represents under 2% of the post-money value; the governance or information rights that accompany it at this dilution level are not publicly stated.

Consensus view: The Cambridge Centre for Alternative Finance and Elliptic's own research team assess that the combination of Nasdaq Ventures and Deutsche Bank in the same syndicate signals a convergence of exchange infrastructure and traditional banking on shared compliance tooling.

Both institutions face the same regulatory pressure: FCA authorisation requirements for crypto and digital assets custody create an immediate demand for transaction monitoring at the billion-per-week scale that Elliptic provides.

Counter-view: CryptoCompare's institutional analytics group argues that Chainalysis, Elliptic's primary competitor, has a larger customer base across US regulatory agencies (FinCEN, OFAC) and that the FCA's liberalisation of UK crypto authorisation benefits both equally. Elliptic's $670m valuation at $120m Series D implies a revenue multiple that compresses the return profile for late-stage investors unless the US government compliance market expands significantly.

Key tension: Whether Elliptic can maintain pricing power in the crypto compliance market as Chainalysis scales in the US market and as blockchain analytics commoditises through open-source tooling and on-chain data availability.

Sources:Elliptic (confirmed by Bloomberg, CoinDesk, The Block)·Elliptic (confirmed by Bloomberg, CoinDesk, The Block)

Mentions:Nasdaq Ventures →Elliptic →British Business Bank →Index Ventures →Deutsche Bank →Financial Conduct Authority →AI Live Testing →OFAC →Cambridge →Nasdaq →British Business Bank South West Investment Fund →One Peak →British Growth Partnership Fund I →

First Reported In

Update #4 · State capital lands on UK tech in nine days

Elliptic (confirmed by Bloomberg, CoinDesk, The Block)· 13 May 2026

Read original →

Causes and effects

Caused by

Business Bank begins direct startup investment

The BBB's dual-instrument £13m Elliptic co-investment uses mandate capital and the British Growth Partnership Fund I unlocked by the April 2026 expansion (ID:2343).

Occurred 6 Apr 2026

Read story →

This Event

Elliptic closes $120m crypto compliance round

Elliptic's round shows institutional financial infrastructure players investing directly in crypto compliance rather than building it in-house, and the BBB deploying two instruments simultaneously (the British Growth Partnership Fund I and its core balance sheet) in a single deal for the first time.

Different Perspectives

Australian Department of Defence (AUKUS AI for Acoustics partner)

Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.

Sofinnova Partners (European VC co-investor in Cytospire Series A)

Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.

Temasek (Singapore sovereign co-investor in Isomorphic Series B)

Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.

Alphabet / Google (majority Isomorphic shareholder, Mountain View)

Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.

DSIT / Liz Kendall, Secretary of State for Science

DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.

Beauhurst / UK startup data analysts

Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.